FIELD: pharmacology.
SUBSTANCE: invention relates to a new compound, namely 1,3-bis(4-methoxybenzoyl)pyrimidine-2,4(1H,3H)-dione corresponding to the structural formula (I) below. Structural formula (I)
.
EFFECT: compounds possess glycated proteins cross-linkage breaking activity and can be used in treatment of diabetes and diseases associated with aging and neurodegenerative amyloid disease, such as Alzheimer's disease.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HALIDES OF 1-(4-TERT-BUTYLPHENYL)-2-{3-[2-(4-FLUORO-PHENOXY)ETHYL]-2-METHYL-3H-BENZIMIDAZOLE-1-YL}ETHANONE WITH PROPERTY OF RUPTURE CROSS-LINKERS OF GLYCATED PROTEINS | 2016 |
|
RU2635112C1 |
| 9-BENZYL-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF THAT EXPRESS PROPERTIES OF DESTROYERS OF TRANSVERSAL CROSS-LINKS OF GLYCOSYLATED PROTEINS | 2016 |
|
RU2627769C1 |
| SODIUM SALT OF 3-NITRO-4-OXO-1,4-DIHYDROPYRAZOLO[5,1-c]-1,2,4-TRIAZINE-8-CARBOXYLIC ACID, DIHYDRATE | 2016 |
|
RU2641107C1 |
| USE OF HETEROCYCLIC HYDRAZONES AS AGENTS HAVING ANTIGLYCATING ACTIVITY | 2016 |
|
RU2658819C2 |
| INHIBITORS OF FORMATION OF GLYCATION END PRODUCTS BASED ON AZO-DERIVATIVE PHENYLSULPHONIC ACIDS | 2016 |
|
RU2634594C1 |
| 2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF | 2018 |
|
RU2716715C2 |
| APPLICATION OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION GLYCATION END PRODUCTS | 2017 |
|
RU2680844C1 |
| SODIUM SALT OF DIETHYL ETHER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID MONOHYDRATE | 2015 |
|
RU2612300C1 |
| APPLICATION OF NITRO-DERIVATIVE PHENOL-SULPHONIC ACIDS AS INHIBITORS OF FINAL GLYCATION PRODUCTS FORMATION | 2016 |
|
RU2628605C1 |
| NEW CANNABIDIOL QUINONE DERIVATIVES | 2014 |
|
RU2667504C2 |
